These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25194471)

  • 1. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presenting efficacy information in direct-to-consumer prescription drug advertisements.
    O'Donoghue AC; Sullivan HW; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2014 May; 95(2):271-80. PubMed ID: 24581929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
    Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
    Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Rupert DJ
    Med Decis Making; 2019 Nov; 39(8):975-985. PubMed ID: 31583947
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
    Limbu Y; Torres IM
    J Health Hum Serv Adm; 2009; 32(1):107-38. PubMed ID: 19558035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs.
    O'Donoghue AC; Sullivan HW; Aikin KJ
    Ann Behav Med; 2014 Dec; 48(3):311-22. PubMed ID: 24682975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
    Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumers' Understanding of FDA Approval Requirements and Composite Scores in Direct-to-Consumer Prescription Drug Print Ads.
    O'Donoghue AC; Sullivan HW; Williams PA; Squire C; Betts KR; Fitts Willoughby J; Parvanta S
    J Health Commun; 2016 Aug; 21(8):927-34. PubMed ID: 27414000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual images of prescription drug benefits in direct-to-consumer television advertisements.
    Sullivan HW; O'Donoghue AC; Lynch M; Johnson M; Davis C; Amoozegar JB; Rupert DJ
    Patient Educ Couns; 2021 Sep; 104(9):2240-2249. PubMed ID: 33618970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumer friendly or reader hostile? An evaluation of the readability of DTC print ads.
    Sheehan K
    Health Mark Q; 2008; 23(4):1-16. PubMed ID: 19042509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumer responses to framing statements preceding the major risk statement in prescription drug DTC TV ads.
    Aikin KJ; Betts KR; Boudewyns V; Johnson M; Davis CN
    Res Social Adm Pharm; 2020 Sep; 16(9):1237-1247. PubMed ID: 31838056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidden in plain sight marketing prescription drugs to consumers in the twentieth century.
    Greene JA; Herzberg D
    Am J Public Health; 2010 May; 100(5):793-803. PubMed ID: 20299640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
    Klara K; Kim J; Ross JS
    J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements.
    Betts KR; Boudewyns V; Aikin KJ; Squire C; Dolina S; Hayes JJ; Southwell BG
    Res Social Adm Pharm; 2018 Oct; 14(10):951-963. PubMed ID: 28844621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selling Health to the Distracted: Consumer Responses to Source Credibility and Ad Appeal Type in a Direct-to-Consumer Advertisement.
    Lemanski JL; Villegas J
    Health Mark Q; 2015; 32(3):217-33. PubMed ID: 26368298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs.
    Faerber AE; Kreling DH
    J Gen Intern Med; 2014 Jan; 29(1):110-8. PubMed ID: 24030427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.